Capital Investment Counsel Inc’s Novartis NVS Stock Holding History

Capital Investment Counsel Inc’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,041	Closed	-$269K	–	138
2015 Q1	$269K	Sell	3,041 -335	-10%	-$29.7K	0.13%	120
2014 Q4	$280K	Sell	3,376 -223	-6%	-$18.5K	0.13%	116
2014 Q3	$304K	Sell	3,599 -168	-4%	-$13.6K	0.15%	113
2014 Q2	$306K	Buy	3,767 +168	+5%	+$13.2K	0.13%	130
2014 Q1	$274K	Buy	3,599 +84	+2%	+$6.12K	0.12%	131
2013 Q4	$253K	Hold	3,515	–	–	0.11%	130
2013 Q3	$242K	Sell	3,515 -335	-9%	-$22.2K	0.12%	132
2013 Q2	$244K	Buy	+3,850	New	+$250K	0.13%	132

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.42% 1-Year Est. Return

Capital Investment Counsel Inc's NVS Position: Q2 2015 in Review

Capital Investment Counsel Inc sold out of Novartis (NVS) in Q2 2015, closing a stake of 3,041 shares — an estimated $269K sold.

Capital Investment Counsel Inc first reported a position in NVS in Q2 2013 and held it in 8 quarters. The position peaked at $306K in Q2 2014. 944 funds tracked by Wall St. Rank hold NVS as of Q2 2015.

Capital Investment Counsel Inc reported no remaining Novartis position as of Q2 2015 after selling out during the quarter.
Capital Investment Counsel Inc sold 3,041 Novartis shares in Q2 2015, an estimated $269K.
Capital Investment Counsel Inc first reported a position in Novartis in Q2 2013 and held it in 8 quarters.
Capital Investment Counsel Inc's Novartis position peaked at $306K in Q2 2014.
944 funds tracked by Wall St. Rank held Novartis as of Q2 2015.

Based on Capital Investment Counsel Inc's 13F filing for Q2 2015, filed 11 Aug 2015.